Analyst Ratings For Insmed (NASDAQ:INSM)
Today, Morgan Stanley initiated coverage on Insmed (NASDAQ:INSM) with a Overweight with a price target of $39.00.
Some recent analyst ratings include
- 3/21/2018-Morgan Stanley initiated coverage with a Overweight rating.
- 1/17/2018-Credit Suisse Group initiated coverage with a Neutral rating.
- 1/4/2018-HC Wainwright Reiterated Rating of Buy.
- 1/4/2018-Robert W. Baird Reiterated Rating of Outperform .
- 11/3/2017-Cowen Reiterated Rating of Buy.
- 9/6/2017-Stifel Nicolaus Reiterated Rating of Buy.
Recent Insider Trading Activity For Insmed (NASDAQ:INSM)
Insmed (NASDAQ:INSM) has insider ownership of 5.10% and institutional ownership of 99.08%.
- On 11/14/2017 Donald J Hayden Jr, Director, sold 15,000 with an average share price of $32.50 per share and the total transaction amounting to $487,500.00.
- On 9/7/2017 Donald J Hayden Jr, Director, sold 45,000 with an average share price of $29.67 per share and the total transaction amounting to $1,335,150.00.
- On 9/6/2017 Melvin Md Sharoky, Director, sold 50,000 with an average share price of $27.37 per share and the total transaction amounting to $1,368,500.00.
- On 5/31/2017 Christine A Pellizzari, General Counsel, bought 10,000 with an average share price of $15.14 per share and the total transaction amounting to $151,400.00.
- On 12/15/2016 Christine A Pellizzari, General Counsel, bought 20,000 with an average share price of $12.81 per share and the total transaction amounting to $256,200.00.
- On 12/14/2016 Myrtle S Potter, Director, sold 6,466 with an average share price of $12.79 per share and the total transaction amounting to $82,700.14.
- On 11/14/2016 Andrew T Drechsler, CFO, sold 45,000 with an average share price of $14.67 per share and the total transaction amounting to $660,150.00.
Recent Trading Activity for Insmed (NASDAQ:INSM)
Shares of Insmed closed the previous trading session at with 0.0 shares trading hands.